Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

15 Aug, 2018, 15:15 BST PolyU Develops Novel Self-fitting Scaffold for Bone Regeneration

Researchers from The Hong Kong Polytechnic University (PolyU) have designed and fabricated a high performing self-fitting bone scaffold by...


14 Aug, 2018, 17:13 BST Blueberry Therapeutics Limited Closes £10m Funding to Support Development of Nanomedicines Portfolio

Blueberry Therapeutics Limited, ("Blueberry Therapeutics") a drug discovery and development company focused on developing innovative nanomedicines...


13 Aug, 2018, 08:09 BST Cantargia Presents Update on the CANFOUR Clinical Trial and Phase IIa Preparations

- 15 patients treated and CAN04 showed a good safety profile - A few more patients to be included to establish maximum tolerated or recommended...


10 Aug, 2018, 11:10 BST Okayama University Research: New Device for Assisting Accurate Hemodialysis Catheter Placement

Researchers at Okayama University report in The Journal of Vascular Access a supporting device for accurately placing hemodialysis catheters on...


10 Aug, 2018, 02:32 BST JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Trastuzumab Biosimilar to Treat Breast Cancer

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European...


10 Aug, 2018, 02:24 BST JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer

JHL Biotech has announced it received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European...


09 Aug, 2018, 19:54 BST InDex Pharmaceuticals Updates Timeline for Top Line Results from the CONDUCT Study to First Half of 2019

InDex Pharmaceuticals Holding AB (publ) today announced an updated timeline for patient recruitment in the ongoing phase IIb study CONDUCT with the...


09 Aug, 2018, 13:10 BST Drug Discovery Outsourcing Market Worth $4.4 Billion by 2025: Grand View Research, Inc.

The global drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR, according to a new report by...


08 Aug, 2018, 09:00 BST Guided Therapy Systems: Invisible Scalpel Set to Target Chronic Pain

- Actisound technology uses Intense Therapeutic Ultrasound to treat musculoskeletal injuries - CE Approval comes as Guided Therapy...


08 Aug, 2018, 08:09 BST Eurocine Vaccines´ Nasal Influenza Vaccine Candidate Immunose™ FLU Showed Good Safety in Older Adults

Eurocine Vaccines today announced good safety and tolerability in older adults, in the second clinical phase I/II study including their...


07 Aug, 2018, 12:29 BST Sanifit Announces Completion of Enrollment in CaLIPSO - its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialysis

Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the...


06 Aug, 2018, 14:30 BST JNCCN--Journal of the National Comprehensive Cancer Network Strengthens Editorial Focus on Original, Impactful Research into Cancer Care Delivery

Journal reaches new heights for readership and impact rating thanks to expanding content, including new studies, panel insights, and NCCN...


06 Aug, 2018, 12:00 BST Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers

- Exclusive license agreement potentially worth more than $120 million in addition to royalties - GBR 1302 is a clinical stage, HER2xCD3...


06 Aug, 2018, 08:00 BST New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA®▼ (edoxaban)

- Hokusai-VTE CANCER study showed that oral edoxaban is non-inferior to subcutaneous injectable dalteparin, for the composite outcome of...


06 Aug, 2018, 08:00 BST Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA

Menarini Ricerche, a company of the Menarini Group, announced today that the sponsorship of the ongoing Phase I/II study that is investigating...


03 Aug, 2018, 16:23 BST Karolinska Institutet Participates in Immunovia's PanFAM-1 Prospective Clinical Study for Early Detection of Pancreatic Cancer Using Blood-based Test

Prospects rise for world's first national screening program. Immunovia AB today announced that the Karolinska Institutet is to participate...


03 Aug, 2018, 11:39 BST Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Parkinson's Disease (PD) Patients Whose Symptoms are Uncontrolled With Oral Medication

Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet...


01 Aug, 2018, 12:16 BST Cantargia Obtains Patent Approval for the Antibody CAN04 (nidanilimab) in China

Cantargia AB announce that the Chinese patent authority, State Intellectual Property Office ("SIPO") has issued a formal approval concerning the...


01 Aug, 2018, 00:01 BST Owen Mumford Provides Support to Achieve Better Blood Samples for Accurate Point-of-Care-Testing (POCT) Results

- Owen Mumford, pioneers of safety lancets for capillary blood sampling, is supporting healthcare professionals gain confidence and...


31 Jul, 2018, 23:50 BST Laekna Acquires Exclusive Worldwide Rights to Two Clinical Stage Oncology Assets

Laekna to Develop and Commercialize Two Oral Akt Inhibitors with Positive Proof-of-concept Results Laekna Inc., a biotechnology company...


31 Jul, 2018, 13:00 BST Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

The TIGERTRIEVER 13 is the smallest profile stentriever, designed to safely retrieve clots from intracranial vessels of 1mm - 2.5mm. Rapid...


31 Jul, 2018, 10:25 BST PharmaMar Announces That the ATLANTIS Study Has Reached the Goal of Patient Recruitment

- ATLANTIS study, in small-cell lung cancer with lurbinectedin, recruited 600 patients in a total of 160 hospital centers in 20...


31 Jul, 2018, 08:00 BST Pfizer's New Report Shows How Behavioural Science Can Help Boost Preventative Healthcare Measures

Released today, a new report based on research by the Economist Intelligence Unit (EIU) and sponsored by Pfizer Vaccines assesses why, despite the...


26 Jul, 2018, 16:00 BST Monash plant science discovery may unlock treatment strategies for genetic diseases in humans

Monash plant scientists have discovered a new molecular mechanism of gene regulation, which could have major implications for the development of...


26 Jul, 2018, 12:48 BST Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today that it has successfully completed a Phase 1 multiple ascending dose...